Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and f ...
Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%)Q1 ...
Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF- (+27%) and APONVIE- (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Health ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company leveraging its proprietary RADR ® artificial intelligence (AI) and machine learning (ML) platform to transform ...
NEW YORK, April 24, 2026 (GLOBE NEWSWIRE)-- Plopii, a Brooklyn-based biotechnology company specializing in consumer wellness products and drug patent development centered on paraxanthine, caffeine's ...
A key sticking point to greater adoption of biosimilar medications by health plans are lawsuits from brand manufacturers ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On December 16, 2025, the European Commission (the "Commission") published a proposal for a European Biotech Act (the "Proposed Biotech Act" ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results